Update Review Article: Spontaneous Bacterial Peritonitis
Abstract
Spontaneous bacterial peritonitis (SBP) is a frequent and severe complication in cirrhotic patients with ascites. To describe spontaneous bacterial peritonitis (SBP) in the context of currently accepted criteria for diagnosis, treatment and prevention. A review of SBP and its associated etiopathogenic factors is presented. Numerous studies on mechanisms of disease, bacteriology, epidemiology, diagnostic markers, and current guidelines for its diagnosis, treatment and prevention are discussed. Peritonitis in patients with ascites in the absence of secondary causes, such as perforation of a viscus, occurs primarily in patients with end-stage liver disease. Enteric organisms, mainly gram-negative bacilli, probably translocate to regional lymph nodes to produce bacteremia and seeding of ascitic fluid. Signs and symptoms of peritonitis are usually subtle. The ascitic fluid polymorphonuclear leukocyte count is the best determinant for early diagnosis and treatment of SBP. Third-generation cephalosporins such as cefotaxime are considered the drugs of choice for treatment, whereas quinolones such as norfloxacin are used to decrease recurrence. Despite increased awareness, early diagnosis, and prompt and effective antimicrobial therapy, SBP recurs frequently and is associated with a high mortality rate. Patients with SBP should be assessed for candidacy for liver transplantation.
Keyword: Spontaneous bacterial peritonitis, Bacteriology, Epidemiology, Diagnostic markers, Cephalosporins
DOI
https://doi.org/10.22270/jddt.v8i6-s.2133References
Bunchorntavakul C, Chamroonkul N, Chavalitdhamrong D. Bacterial infections in cirrhosis: A critical review and practical guidance, World Journal of Hepatology 2016; 8:307-321.
Albillos A, Lario M, Álvarez-Mon M. Cirrhosis-associated immune dysfunction: distinctive features and clinical relevance, Journal of Hepatology 2014; 61:1385-1396.
Jalan R, Fernandez J, Wiest R, et al., Bacterial infections in cirrhosis: a position statement based on the EASL Special Conference 2013, Journal of Hepatology 2014; 60:1310-1324.
Tsochatzis EA, Bosch J, Burroughs AK. Liver cirrhosis. Lancet. 2014; 383(9930):1749-1761.
Dionigi E, Garcovich M, Borzio M, et al., Bacterial infections change natural history of cirrhosis irrespective of liver disease severity, American Journal of Gastroenterology 2017; 12:588-596.
Jalan R, Yurdaydin C, Bajaj JS et al., World gastroenterology organization working party. Toward an improved definition of acute-on-chronic liver failure, Gastroenterology 2014; 147:4-10.
Conn HO. Spontaneous peritonitis and bacteremia in laennec’s cirrhosis caused by enteric organisms. a relatively common but rarely recognized syndrome, Annals of Internal Medicine 1964; 60:568-80.
Garcia-Tsao G. Spontaneous bacterial peritonitis: A historical perspective, Journal of Hepatology 2004; 41(4):522-7.
Guarner C, Runyon BA. Spontaneous bacterial peritonitis: Pathogenesis, diagnosis and management, Gastroenterologist 1995; 3(4):311-28.
Fernández J, Navasa M, Gomez J, et al., Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis, Hepatology 2002; 35:140-148.
Singh N, Wagener MM, Gayoski T. Changing epidemiology and predictors of mortality in patients with spontaneous bacterial peritonitis at liver transplant unit, Clinical Microbiology and Infection 2003; 9:531-537.
Sette Jr H, Mies S, Barros MFA, et al., Peritonite bacteriana espontânea, Rev Paul Media 1986; 104:292-297.
Hurwich DB, Lindor KD, Hay JE, et al., Prevalence of peritonitis and the ascitic fluid protein concentration among chronic liver disease patients, American Journal of Gastroenterology 1993; 88:1254-1257.
Mattos A. Peritonite bacteriana espontânea e suas variantes; epidemiologia diagnóstico e história natural, GED1994; 13:97-105.
Jeffries MA, Stern MA, Gunaratnam NT, et al., Unsuspected infection is infrequent in asymptomatic outpatients with refractory ascites undergoing therapeutic paracenteses, American Journal of Gastroenterology 1999; 94:2972-2976.
Thuluvath PJ, Morss S, Thompson R. Spontaneous bacterial peritonitis – In-hospital mortality, predictors of survival, and health care costs from 1988 to 1998, American Journal of Gastroenterology 2001; 96:1232-1236.
Rimola A, Navasa M, Arroyo V. Experience with cefotaxime in the treatment of spontaneous bacterial peritonitis in cirrhosis, Diagnostic Microbiology and Infectious Disease1995; 22:141-145.
Nousbaum JB, Cadranel JF, Nahon P, et al., Diagnostic accuracy of the Multistix 8 SG reagent strip in diagnosis of spontaneous bacterial peritonitis, Hepatology, 2007; 45:1275-1281.
Evans LT, Kim WR, Poterucha JJ, et al., Spontaneous bacterial peritonitis in asymptomatic outpatients with cirrhotic ascites, Hepatology2003; 37:897-901.
Castellote J, Girbau A, Maisterra S, et al., Spontaneous bacterial peritonitis and bacterascites prevalence in asymptomatic cirrhotic outpatients undergoing large-volume paracentesis, Journal of Gastroenterology and Hepatology 2008; 23:256-259.
Garcia-Tsao G, Lee FY, Barden GE, et al., Bacterial translocation to mesenteric lymph nodes is increased in cirrhotic rats with ascites, Gastroenterology1995; 108:1835-1841.
Cirera I, Bauer TM, Navasa M, et al., Bacterial translocation of enteric organisms in patients with cirrhosis, Journal of Hepatology 2001; 34:32-37.
Rimola A, Bory F, Teres J, et al., Oral, nonabsorbable antibiotics prevent infection in cirrhotics with gastrointestinal hemorrhage, Hepatology1985; 5:463-467.
Ginès P, Martin PY, Neiderbeger M. Prognostic signifcance of renal dysfunction in cirrhosis, Kidney International Supplements 1997; 61:s77-82.
Soriano G, Guarner C, Tomas A, et al., Norfloxacin prevents bacterial infection in cirrhotics with gastrointestinal hemorrhage, Gastroenterology1992; 103:1267-1272.
Bauer TM, Steinbruckner B, Brinkmann FE, et al., Small intestinal bacterial overgrowth in patients with cirrhosis. Prevalence and relation with spontaneous bacterial peritonitis, American Journal of Gastroenterology 2001; 96:2962-2967.
Chang CS, Chen GH, Lien HC, et al., Small intestine dysmotility and bacterial overgrowth in cirrhotic patients with spontaneous bacterial peritonitis, Hepatology 1998; 28:1187-1190.
Runyon BA, Morrissey RL, Hoefs JC, et al., Opsonic activity of human ascitic fl uid: a potentially important protective mechanism against spontaneous bacterial peritonitis, Hepatology1985;5:634-637.
Guarner C, Runyon BA. Spontaneous bacterial peritonitis: pathogenesis, diagnosis and management, Gastroenterologist, 1995; 3:311-328.
Homann C, Varming K, Hogasen K, et al., Acquired C3 defi ciency in patients with alcoholic cirrhosis predisposes to infection and increased mortality, Gut 1997; 40:544-549.
Christou L, Pappas G, Falagas ME. Bacterial infection-related mor bidity and mortality in cirrhosis, American Journal of Gastroenterology 2007; 102:1510-1517.
Gines P, Schrier RW. Hepatorenal syndrome and renal dysfunction associated with liver disease. In: Schrier RW, Gottschalk CW, eds. Diseases of the Kidney, 6th edn. Boston: Little Brown, 1997: 2099,127.
Gines P, Fernandez-Esparrach G, Arroyo V, Rodes J. Pathogenesis of ascites in cirrhosis, Semin Liver Diseases 1997; 17:175-189.
D'Amico G, Morabito A, Pagliaro L, Marubini E. The liver study group of v cervello hospital. Survival and prognostic indicators in compensated and decompensated cirrhosis, Digestive Diseases and Sciences 1986; 31(5):468-475.
Gines P, Martin PY, Neiderbeger M. Prognostic significance of renal dysfunction in cirrhosis, Kidney International Supplements 1997; 61:s77-82.
Schrier RW, Arroyo V, Bernardi M, et al., Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis, Hepatology 1988; 8:1151-1157.
Bichet DG, Van Putten VJ, Schrier RW. Potential role of increased sympathetic activity in impaired sodium and water excretion in cirrhosis, New England Journal of Medicine 1982; 307:1552-1557.
Arroyo V, Gines P. Renal function abnormalities in cirrhosis, European Journal of Gastroenterology & Hepatology 1991; 3: 714-720.
Cardona AH, Guerra JJH, Gutierrez JCR, Update on spontaneous bacterial peritonitis, Rev Col Gastroenterol 2015; 30(3):310-318.
Sheer TA, Bruce A. Runyon spontaneous bacterial peritonitis, Dig Dis 2005; 23:39-46
Conn HO. Spontaneous peritonitis and bacteremia in Laennec’s cirrhosis caused by enteric organisms. A relatively common but rarely recognized syndrome, Annals of Internal Medicine 1964; 60:568-580.
Kerr DNS, Pearson DT, Read AE. Infection of ascitic fluid in patients with hepatic cirrhosis. Gut 1963; 4:394-398.
Fernandez J, Navasa M, Gomez J, et al., Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis, Hepatology 2002; 35:140-148.
Novovic S, Semb S, Olsen H, et al., First-line treatment with cephalosporins in spontaneous bacterial peritonitis provides poor antibiotic coverage, Scandinavian Journal of Gastroenterology 2012; 47:212-216.
Dever JB, Sheikh MY. Spontaneous bacterial peritonitis – bacteriology, diagnosis, treatment, risk factors and prevention, Alimentary Pharmacology and Therapeutics2015; 1-16.
Oey RC, De Man RA, Erler NS, et al., Microbiology and antibiotic susceptibility patterns in spontaneous bacterial peritonitis: A study of two Dutch cohorts at a 10-year interval, United European Gastroenterology Journal 2018; 6(4):614-621.
Yang Y, Li L, Qu C, et al., Diagnostic accuracy of serum procalcitonin for spontaneous bacterial peritonitis due to end-stage liver disease, a metaanalysis, Medicine (Baltimore) 2015; 94:e2077.
Burri E, Schulte F, Muser J, Meier R, Beglinger C. Measurement of calprotectin in ascitic fluid to identify elevated polymorphonuclear cell count, World Journal of Gastroenterology 2013; 19:2028-2036.
Lutz P, Pfarr K, Nischalke HD, et al., The ratio of calprotectin to total protein as a diagnostic and prognostic marker for spontaneous bacterial peritonitis in patients with liver cirrhosis and ascites, Clinical Chemistry and Laboratory Medicine 2015; 53: 2031-2039.
Castellote J, López C, Gornals J, et al., Rapid diagnosis of spontaneous bacterial peritonitis by use of reagent strips, Hepatology 2003; 37:893-896.
Oey RC, Kuiper JJ, Van Buuren HR, De Man RA. Reagent strips are efficient to rule out spontaneous bacterial peritonitis in cirrhotics, Netherlands journal of medicine 2016; 74:257-261.
Koulaouzidis A. Diagnosis of spontaneous bacterial peritonitis: an update on leucocyte esterase reagent strips, World Journal of Gastroenterology 2011; 17:1091-1094.
Shizuma T. Spontaneous bacterial and fungal peritonitis in patients with liver cirrhosis: A literature review. World Journal of Hepatology 2018; 10(2):254-266.
Shizuma T. Diagnostic laboratory markers for spontaneous bacterial peritonitis, Annals of Clinical and Laboratory Research 2016; 4 (4):131-136.
Moore KP, Aithal GP. Guidelines on the management of ascites in cirrhosis, Gut 2006; 55 (Suppl 6):1-12.
Koulaouzidis A, Bhat S, Saeed AA. Spontaneous bacterial peritonitis, World Journal of Gastroenterology, 2009; 15 (9):1042-1049.
Wiest R, Krag A, Gerbes A. Spontaneous bacterial peritonitis: recent guidelines and beyond, Gut 2012; 61(2):297–310.
Moore KP, Aithal GP. Guidelines on the management of ascites in cirrhosis, Gut 2006; 55 (Suppl 6):1-12.
Garcia-Tsao G, Lim J, Members of Veterans Affairs Hepatitis C Resource Center Program, Management and treatment of patients with cirrhosis and portal hypertension: recommendations from the department of veterans affairs hepatitis C resource center program and the national hepatitis C program, The American Journal of Gastroenterology 2009; 104(7):1802-1829.
European Association for the Study of the Liver, EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis, Journal of Hepatology 2010; 53(3):397-417.
Runyon BA, Hoefs JC. Ascitic fluid analysis in the differentiation of spontaneous bacterial peritonitis from gastrointestinal tract perforation into ascitic fluid, Hepatology 1984; 4(3):447-450.
Nguyen-Khac E, Cadranel J.-F, Theveno T, Nousbaum J.-B. The utility of reagent strips in the diagnosis of infected ascites in cirrhotic patients, Alimentary Pharmacology and Therapeutics 2008; 28(3):282-288.
Koulaouzidis A, Diagnosis of spontaneous bacterial peritonitis: an update on leucocyte esterase reagent strips, World Journal of Gastroenterology 2011; 17(9):1091-1094.
Mendler MH, Agarwal A, Trimzi M, et al., A new highly sensitive point of care screen for spontaneous bacterial peritonitis using the leukocyte esterase method, Journal of Hepatology 2010; 53(3):477-483.
Corless CE, Guiver M, Borrow R, et al., Contamination and sensitivity issues with a real-time universal 16s rRNA PCR, Journal of Clinical Microbiology 2000; 38(5):1747-1752.
Philipp S, Huemer HP, Irschick E U, Gassner C. Obstacles of multiplex real-time PCR for bacterial 16S rDNA: primer specifity and DNA decontamination of Taq polymerase, Transfusion Medicine and Hemotherapy 2010; 37(1):21-28.
Evans GE, Murdoch DR, Anderson TP, et al., Contamination of Qiagen DNA extraction kits with Legionella DNA, Journal of Clinical Microbiology 2003; 41(7):3452-3453.
Tilburg JJHC, Nabuurs-Franssen MH, Van Hannen EJ, et al., Contamination of commercial PCR master mix with DNA from Coxiella burnetii, Journal of Clinical Microbiology 2010; 48(12):4634-4635.
Matsuhisa A, Saito Y, Sakamoto Y, et al., Detection of bacteria in phagocyte-smears from septicemia-suspected blood by in situ hybridization using biotinylated probes, Microbiology and Immunology 1994; 38(7):511-517.
Shimada J, Hayashi I, Inamatsu T., et al., Clinical trial of in-situ hybridization method for the rapid diagnosis of sepsis, Journal of Infection and Chemotherapy 1999; 5(1):21-31.
Kudo M, Matsuo Y, Nakasendo A, et al., Potential clinical benefit of the in situ hybridization method for the diagnosis of sepsis, Journal of Infection and Chemotherapy 2009; 15(1),23-26.
Enomoto H, Inoue SI, Matsuhisa A, Nishiguchi S. Diagnosis of spontaneous bacterial peritonitis and an in situ hybridization approach to detect an ‘‘unidentified’’ pathogen, International Journal of Hepatology 2014.
Runyon BA. AASLD practice guidelines: management of adult patients with ascites due to cirrhosis: an update, Hepatology 2009; 49:2087-107.
Navasa M, Follo A, Llovet JM, et al., Randomized, comparative study of oral ofloxacin versus intravenous cefotaxime in spontaneous bacterial peritonitis, Gastroenterology 1996; 111:1011-1017.
Terg R, Cobas S, Fassio E, et al., Oral ciprofloxacin after a short course of intravenous ciprofloxacin in the treatment of spontaneous bacterial peritonitis: results of a multicenter, randomized study, Journal of Hepatology 2000; 33:564-569.
Campillo B, Dupeyron C, Richardet JP, et al., Epidemiology of severe hospital acquired infections in patients with liver cirrhosis: effect of long-term administration of norfloxacin, Clinical Infectious Diseases 1998; 26:1066-1070.
Sort P, Navasa M, Arroyo V, et al., Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis, New England Journal of Medicine 1999; 341:403-409.
Signal SH, Stanca CM, Fernandez J, et al., Restricted use of albumin for spontaneous bacterial peritonitis, Gut 2007; 56: 597-599.
Singh N, Gayowski T, Yu VL, et al., Trimethoprim-sulfamethoxazole for the prevention of spontaneous bacterial peritonitis in cirrhosis: a randomized trial, Annals of Internal Medicine 1995; 122:595-598.
Hanouneh MA, Hanouneh IA, Hashash JG, et al., The role of rifaximin in the primary prophylaxis of spontaneous bacterial peritonitis in patients with liver cirrhosis, Journal of Clinical Gastroenterology 2012; 46:709-715.
Fiore M, Maraolo AE, Leone S, et al., Spontaneous peritonitis in critically ill cirrhotic patients: a diagnostic algorithm for clinicians and future perspectives, Therapeutics and Clinical Risk Management 2017;13:1409-1414.
Fiore M, Maraolo AE, Gentile I, et al., Current concepts and future strategies in the antimicrobial therapy of emerging Gram-positive spontaneous bacterial peritonitis, World Journal of Hepatology 2017; 9(30):1166-1.
Published
Abstract Display: 694 
PDF Downloads: 529 How to Cite
Issue
Section
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
How to Cite
.